CorporateSun Pharma Gets Ratings Boost From Moody's, S&P Over $11.75-Bn Organon & Co Acquisition BidBY PTI
IndustryWe Are Becoming a Solutions Company, But Will Remain Wind-First: Girish Tanti, Co-founder, SuzlonBY Himanshu Ojha
Corporate‘We Are Working with Hard-to-Abate Industries to Go Green’: Suzlon’s Girish TantiBY Parth Singh
CorporateSun Pharma–Organon Deal: Where Does It Rank in the List of Outgoing Acquisitions?BY Outlook Business Desk
CorporateSun Pharma Partners With Royal Challengers Bengaluru As Principal Sponsor For 3-Year PeriodBY PTI
CorporateGautam Adani, Mukesh Ambani Among Billionaires Hit by Stock Market Slump| Full List HereBY Outlook Business Desk
